Trial results for the Pinnacle RSA Study, investigating acetabular shell migration in patients with osteoarthritis, were posted on ClinicalTrials.gov on 2025-10-21, reporting an overall mean superior cup migration of 0.055 mm at 2 years post-implantation.

Background

Osteoarthritis and degenerative arthritis are common conditions often requiring total hip arthroplasty. The stability of the acetabular component (cup) is crucial for implant longevity. Superior cup migration, or subsidence, indicates micromotion and potential loosening. Radiostereometric Analysis (RSA) precisely measures these small implant movements, providing vital data for assessing performance.

Trial design

This Phase NA study, which was terminated, enrolled 100 participants with Osteoarthritis and Degenerative Arthritis. The primary objective was to establish the mean superior cup migration of the Pinnacle Acetabular Shell using model-based RSA over two years post-implantation. The primary endpoint was the mean vertical subsidence (superior cup migration) at 2 years, measured with RSA, summarized for each surgical approach and combined.

Key results

The trial reported key measurements for superior cup migration (subsidence) of the Pinnacle Acetabular Shell:

What this means

The posted results detail the Pinnacle Acetabular Shell's migration over various time points up to two years post-implantation in osteoarthritis patients. The reported mean subsidence values, generally in the hundredths of a millimeter, suggest relative implant stability. Variations were observed across different surgical approaches. This data informs orthopedic surgeons in selecting devices and techniques for total hip arthroplasty, aiming to improve long-term patient outcomes. No comparative analyses or statistical significance values were reported.

Source

The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT04070989, titled "Pinnacle RSA Study", were posted on 2025-10-21 on clinicaltrials.gov.